The Risks of Stroke and Bleeding for Warfarin Use in Hemodialysis Patients with Atrial Fibrillation: A Systemic Review and A Meta-Analysis

The efficacy and safety of warfarin therapy in hemodialysis (HD) patients with fibrillation (AF) remains controversial. Thus, we performed up to date, the first meta-analysis about the risks of stroke and bleeding of warfarin treatment in these populations.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Source Type: research